scholarly journals The Meaning Of Questionnaires In Assessing The Quality Of Life Of Patients With Type 2 Diabetes On Software Hemodialysis

Author(s):  
Kholikov Alisher Yusupovich ◽  
◽  
Urmanova Yulduz Makhkamovna ◽  

The aim of the study. To study the clinical characteristic and quality of life of the patients with type 2 diabetes mellitus. Material and methods. We examined and examined a total of 80 patients with diabetic nephropathy on program hemodialysis for the period from January 1, 2018, to January 1, 2020. Results. In this article, the authors analyze 80 cases of diabetic nephropathy that were on programmed hemodialysis. Of these, 32 women, 48 men. The results also confirm the literature that patients with type 2 diabetes mellitus have a low quality of life indicators before hemodialysis. Conclusions. A questionnaire to determine the quality indicators - WHOQOL-BREF, MMSE, Hamilton depression scale are the most sensitive and informative to determine the quality of life in patients with chronic kidney disease.

2021 ◽  
Vol 14 (3) ◽  
Author(s):  
Y Urmanova ◽  
A Kholikov

Aim. To assess the quality of life of patients with type 2 diabetes before treatment with hemodialysis using the WHO Brief Questionnaire for the Assessment of Quality of Life (WHOQOL-BREF) and the Hamilton Depression Scale, taking into account the degree of neuromarker S100.Material and methods. We examined and examined in total for the period from January 1, 2019 to January 1, 2021 - 90 patients suffering from type 2 diabetes mellitus with chronic renal failure on programmed hemodialysis.Results. In this article, the authors analyze 90 cases of grade 5 diabetic nephropathy who were on programmed hemodialysis. 43 of them women and 47 men. The obtained results also confirm the literature data that patients with type 2 diabetes mellitus have low quality of life indicators before programmed hemodialysis.Conclusions. The obtained results also confirm the literature data on the need to assess the quality of life of patients with type 2 diabetes against the background of complex therapy and the duration of the hemodialysis treatment.


Author(s):  
Mohammed Osama Akhtar ◽  
Syed Saud Ahmed ◽  
Zohair Jamil Gazzaz ◽  
Danyah Rizwanulla Sheriff

Depression is one of the commonest psychiatric disorders and is a prominent reason for major health problems worldwide. The prevalence and the dysfunction, morbidity, suffering, and economic burden. Depression can lead to upsurge in the health-seeking performance, diminished excellence of life and increased propensity for desperate tendencies. In the majority of the cases, the affected patients report late and owing to various scales of assessing depression, patients with depressive disorder are often undertreated. As per the Global Burden of Disease report the prevalence of depression is 1.9% among men and 3.2% for women and the overall one-year prevalence increases to 5.8% in men and 9.5% in women. Given the existing epidemiological evolution and demographic, the impact of unhappiness can be tremendous by 2020 with the burden of depression at about 5.7% of all the illnesses. The morbidity bearing will be so huge that and it would be the most important reason for disability-adjusted life years (DALYs), next only to ischemic heart disease. This education expected at to assess the prevalence and correlates of depression among type 2 diabetes mellitus patients and impact of treatment on diabetic status, glycemic quality and control of life after 6 months. The scales used in this study was Mini international neuropsychiatric interview – 6.0 , Hamilton Depression Scale (HAM-D), WHO Quality Of Life (WHO-QOL) – BREF scales, Morisky 8-item Medication Adherence Questionnaire. The study has highlighted the prevalence of depression in the study population, positive impact of depression on the treatment compliance, glycemic control and quality of life of the affected patients.


Medicina ◽  
2009 ◽  
Vol 45 (2) ◽  
pp. 85 ◽  
Author(s):  
Lina Lašaitė ◽  
Jūratė Lašienė ◽  
Gintautas Kazanavičius ◽  
Antanas Goštautas

The aim of the study was to evaluate associations of emotional state and quality of life with lipid concentration, duration of the disease, and the way of treating the disease in males and females with type 2 diabetes mellitus. A total of 53 persons with type 2 diabetes mellitus (27 males and 26 females; mean age, 58.7±8.9 years) and 56 healthy persons (26 males and 30 females; mean age, 54.7±8.3 years) participated in the study. Emotional state was evaluated by means of Profile of Mood State and quality of life by means of WHO Brief Quality of Life Questionnaire. Emotional state and quality of life were significantly worse, tension-anxiety and fatigue-inertia were significantly higher, vigor-activity was significantly lower in male patients with type 2 diabetes mellitus than in healthy males. In females, no significant differences in emotional state and quality of life comparing type 2 diabetes mellitus group and controls were detected. In females with type 2 diabetes mellitus, emotional state and quality of life were significantly better, scores of tension-anxiety, depression dejection, anger-hostility, and fatigue-inertia were significantly lower, and score of vigor-activity was significantly higher than in males with type 2 diabetes mellitus. Some significant correlations were found. In males, vigor-activity correlated with total cholesterol level and negatively correlated with triglyceride level. In females, significant correlations were found between scores of emotional state (tension-anxiety, depression-dejection, confusion-bewilderment, and total score of emotional state) and lipid levels (total cholesterol, triglyceride, and low-density lipoprotein cholesterol levels). There were no significant associations of emotional state and quality of life with duration of the disease in males and females with type 2 diabetes mellitus. No significant differences in emotional state and quality of life were found between males and females with type 2 diabetes mellitus, who were treated with oral antidiabetic preparations and insulin preparations.


2021 ◽  
Vol 25 (5) ◽  
pp. 432
Author(s):  
ManashP Baruah ◽  
Ananya Bhowmick ◽  
Seema Bhuyan ◽  
SonaliB Bhuyan ◽  
Jumi Deka ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document